CHARCOT-MARIE-TOOTH DISEASE TYPE 1A
Clinical trials for CHARCOT-MARIE-TOOTH DISEASE TYPE 1A explained in plain language.
Never miss a new study
Get alerted when new CHARCOT-MARIE-TOOTH DISEASE TYPE 1A trials appear
Sign up with your email to follow new studies for CHARCOT-MARIE-TOOTH DISEASE TYPE 1A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cells injected to fight rare nerve disease
Disease control Recruiting nowThis early-phase trial tests a stem cell product called EN001 in 27 adults with Charcot-Marie-Tooth disease type 1A, a genetic nerve disorder that causes muscle weakness. The study has two parts: first, an open-label phase to check safety and find the right dose; second, a placeb…
Matched conditions: CHARCOT-MARIE-TOOTH DISEASE TYPE 1A
Phase: PHASE1, PHASE2 • Sponsor: ENCell • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug EDK060 enters first human tests for nerve disease CMT1A
Disease control Recruiting nowThis early-stage trial tests a new drug called EDK060 in 28 adults with Charcot-Marie-Tooth type 1A, a genetic nerve disorder. Participants receive a single dose of EDK060 or a placebo to check safety and how the drug moves through the body. The goal is to see if EDK060 is safe e…
Matched conditions: CHARCOT-MARIE-TOOTH DISEASE TYPE 1A
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC